You are here

NICE

AbbVie’s CLL drug Venclyxto too expensive for NHS, says NICE

Pharmaforum

Fri, 10/26/18 - 09:54 am

Rituxan/MabThera

NICE spurns Lilly’s breast cancer drug Verzenio in favor of rivals from Pfizer and Novartisspir

Fierce Pharma

Sat, 10/20/18 - 10:37 pm

NICE rejects Novartis’ CAR-T in adult lymphoma

Pharmaforum

Wed, 09/19/18 - 11:22 pm

diffuse large B-cell lymphoma

MS Society protests NICE rejection of Ocrevus for primary progressive MS

BioCentury

Mon, 09/10/18 - 12:16 am

multiple sclerosis

UK rejects Gilead's CAR-T cancer cell therapy as too expensive

Reuters

Tue, 08/28/18 - 11:51 am

Gilead Sciences

Biogen's Spinraza gets an early no-go from NICE

Biopharma Dive

Wed, 08/15/18 - 09:57 am

spinal muscular atrophy

Vertex’s fight club rule: Block new treatments to cystic fibrosis patients until Orkambi is reimbursed properly

Endpoints

Mon, 08/13/18 - 11:18 am

Vertex Pharmaceuticals

cystic fibrosis

tezacaftor/ivacaftor

NICE says yes to AstraZeneca’s Fasenra, but only when its GSK rival can’t be used

Fierce Pharma

Sun, 07/22/18 - 12:21 pm

Sanofi's Dupixent scores NICE recommendation after price cut

Fierce Pharma

Fri, 06/22/18 - 12:06 pm

atopic dermatitis

Johnson & Johnson’s Tremfya Approved for Reimbursement in the UK and Germany

CP Wire

Wed, 06/13/18 - 10:19 pm

Sanofi blockbuster-to-be skin drug Dupixent fails to win gatekeeper's backing

Fierce Pharma

Tue, 04/3/18 - 10:59 pm

Merck's Keytruda shows up its rivals with NICE backing in bladder cancer

Fierce Pharma

Fri, 03/16/18 - 09:18 pm

Pfizer, Merck KGaA nab NICE's favor for Bavencio in Merkel cell carcinoma

Fierce Pharma

Sat, 03/3/18 - 10:42 am

Merkel cell carcinoma

NICE nods for AbbVie in hep C and Novartis in lung cancer

Pharma Times

Sun, 12/10/17 - 09:53 am

ALK-positive non-small cell lung cancer

Pfizer's Ibrance, Novartis' Kisqali go to battle in England after discounts twin NICE recommendations

Fierce Pharma

Thu, 11/16/17 - 11:07 am

GSK picks up NICE recommendation for Strimvelis, a €594,000 gene therapy

Fierce Pharma

Mon, 10/23/17 - 09:55 pm

Pharma's legal challenge to U.K. cost clampdown gets shot down

Fierce Pharma

Wed, 10/4/17 - 07:08 pm

Discount helps NICE flip-flop on Teva's severe asthma contender, Cinqair

Fierce Pharma

Thu, 07/20/17 - 06:10 pm

Teva Pharmaceutical

Lilly’s Olumiant, spurned by FDA, gets nod from NICE

Fierce Pharma

Sat, 07/1/17 - 09:26 am

rheumatoid arthritis

Pfizer, awaiting a final NICE verdict, doles out free Ibrance in the U.K.

Fierce Pharma

Sun, 05/7/17 - 10:23 am

Pages